Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2003 1
2006 1
2009 2
2011 1
2012 2
2013 6
2014 11
2015 9
2016 15
2017 12
2018 11
2019 23
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

96 results
Results by year
Filters applied: . Clear all
Page 1
Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.
Rijavec E, Coco S, Genova C, Rossi G, Longo L, Grossi F. Rijavec E, et al. Among authors: genova c. Cancers (Basel). 2019 Dec 19;12(1):17. doi: 10.3390/cancers12010017. Cancers (Basel). 2019. PMID: 31861557 Free PMC article. Review.
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine.
Tagliamento M, Rijavec E, Barletta G, Biello F, Rossi G, Grossi F, Genova C. Tagliamento M, et al. Among authors: genova c. Expert Opin Biol Ther. 2018 Jul;18(7):829-835. doi: 10.1080/14712598.2018.1492539. Epub 2018 Jul 4. Expert Opin Biol Ther. 2018. PMID: 29936901 Review.
Harnessing NK Cells for Cancer Treatment.
Minetto P, Guolo F, Pesce S, Greppi M, Obino V, Ferretti E, Sivori S, Genova C, Lemoli RM, Marcenaro E. Minetto P, et al. Among authors: genova c. Front Immunol. 2019 Dec 6;10:2836. doi: 10.3389/fimmu.2019.02836. eCollection 2019. Front Immunol. 2019. PMID: 31867006 Free PMC article. Review.
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells.
Pesce S, Greppi M, Grossi F, Del Zotto G, Moretta L, Sivori S, Genova C, Marcenaro E. Pesce S, et al. Among authors: genova c. Front Immunol. 2019 Jun 4;10:1242. doi: 10.3389/fimmu.2019.01242. eCollection 2019. Front Immunol. 2019. PMID: 31214193 Free PMC article. Review.
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer.
Tagliamento M, Genova C, Rijavec E, Rossi G, Biello F, Dal Bello MG, Alama A, Coco S, Boccardo S, Grossi F. Tagliamento M, et al. Among authors: genova c. Expert Opin Pharmacother. 2018 Dec;19(18):2055-2062. doi: 10.1080/14656566.2018.1540591. Epub 2018 Nov 3. Expert Opin Pharmacother. 2018. PMID: 30392436 Review.
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.
Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MH, Chen G, Franklin WA, Gandara DR, Genova C, Brovsky KA, Joshi MM, Merrick DT, Richards WG, Rivard CJ, Harpole DH, Tsao MS, van Bokhoven A, Shepherd FA, Hirsch FR. Yu H, et al. Among authors: genova c. J Thorac Oncol. 2019 Jan;14(1):25-36. doi: 10.1016/j.jtho.2018.09.006. Epub 2018 Sep 22. J Thorac Oncol. 2019. PMID: 30253973 Free PMC article.
Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence.
Ricciuti B, Genova C, Crinò L, Libra M, Leonardi GC. Ricciuti B, et al. Among authors: genova c. Onco Targets Ther. 2019 Apr 30;12:3171-3179. doi: 10.2147/OTT.S177051. eCollection 2019. Onco Targets Ther. 2019. PMID: 31118670 Free PMC article.
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.
Ricciuti B, Genova C, De Giglio A, Bassanelli M, Dal Bello MG, Metro G, Brambilla M, Baglivo S, Grossi F, Chiari R. Ricciuti B, et al. Among authors: genova c. J Cancer Res Clin Oncol. 2019 Feb;145(2):479-485. doi: 10.1007/s00432-018-2805-3. Epub 2018 Dec 1. J Cancer Res Clin Oncol. 2019. PMID: 30506406
Antibody-drug conjugates for lung cancer in the era of personalized oncology.
Ricciuti B, Lamberti G, Andrini E, Genova C, De Giglio A, Bianconi V, Sahebkar A, Chiari R, Pirro M. Ricciuti B, et al. Among authors: genova c. Semin Cancer Biol. 2019 Dec 30:S1044-579X(19)30424-9. doi: 10.1016/j.semcancer.2019.12.024. Online ahead of print. Semin Cancer Biol. 2019. PMID: 31899248 Review.
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient.
Rossi G, Russo A, Tagliamento M, Tuzi A, Nigro O, Vallome G, Sini C, Grassi M, Dal Bello MG, Coco S, Longo L, Zullo L, Tanda ET, Dellepiane C, Pronzato P, Genova C. Rossi G, et al. Among authors: genova c. Cancers (Basel). 2020 Apr 30;12(5):1125. doi: 10.3390/cancers12051125. Cancers (Basel). 2020. PMID: 32365882 Free PMC article. Review.
96 results
Jump to page
Feedback